These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1850330)

  • 1. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
    Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
    Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
    Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
    Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
    Bastien NR; Juneau AV; Ouellette J; Lambert C
    Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
    Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
    J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
    Turcani M; Rupp H
    Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
    Ma M; Watanabe K; Wahed MI; Inoue M; Sekiguchi T; Kouda T; Ohta Y; Nakazawa M; Yoshida Y; Yamamoto T; Hanawa H; Kodama M; Fuse K; Aizawa Y
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
    Jondeau G; Dib JC; Dubourg O; Bourdarias JP
    Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
    Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
    Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
    Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
    Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinapril: overview of preclinical data.
    Kaplan HR; Taylor DG; Olson SC
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of quinapril on myocardial function, ventricular remodeling and cardiac cytokine expression in congestive heart failure in the rat.
    We GC; Siroi MG; Qu R; Liu P; Roulea JL
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):29-36. PubMed ID: 12085975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP; Elsner D; Riegger GA
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.